Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
Hyangsoon Noh(The University of Texas MD Anderson Cancer Center), Shulin Li(The University of Texas MD Anderson Cancer Center)
Cited by 54
Related Papers
EMT, CTCs and CSCs in tumor relapse and drug-resistance
|Oncotarget|2015|464
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
|Scientific Reports|2016|195
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
|Nature Communications|2019|119